Ambulatory BP monitoring has drawbacks for CVD risk assessment

12/18/2009 | Medscape (free registration)

Ambulatory blood pressure monitoring may be a less reliable way to assess cardiovascular disease risk because it wakes people at night and makes them less active during the day. The end result is that it prevents dipping, the lowering of BP during sleep, and that affects risk assessment, researchers said.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC